Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 220

1.

Serological, molecular and clinicopathological findings associated with Leishmania infantum infection in cats in Northern Italy.

Urbani L, Tirolo A, Salvatore D, Tumbarello M, Segatore S, Battilani M, Balboni A, Dondi F.

J Feline Med Surg. 2020 Jan 20:1098612X19895067. doi: 10.1177/1098612X19895067. [Epub ahead of print]

PMID:
31957532
2.

Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains.

Tumbarello M, Raffaelli F, Peghin M, Losito AR, Chirico L, Giuliano G, Spanu T, Sartor A, Fiori B, Bassetti M.

Int J Antimicrob Agents. 2020 Jan 10:105900. doi: 10.1016/j.ijantimicag.2020.105900. [Epub ahead of print]

PMID:
31931150
3.

Predictors of mortality in solid-organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia.

Pérez-Nadales E, Gutiérrez-Gutiérrez B, Natera AM, Abdala E, Reina Magalhães M, Mularoni A, Monaco F, Pierrotti LC, Freire MP, Iyer RN, Metha S, Calvi EG, Tumbarello M, Falcone M, Fernández-Ruiz M, Costa-Mateo JM, Rana MM, Strabelli TMV, Paul M, Fariñas MC, Clemente WT, Roilides E, Muñoz García P, Dewispelaere L, Loeches B, Lowman W, Tan BH, Escudero-Sánchez R, Bodro Marimont M, Grossi PA, Soldani F, Gunseren F, Nestorova N, Pascual Á, Martínez-Martínez L, Aguado JM, Rodríguez-Baño J, Torre-Cisneros J; INCREMENT-SOT Investigators.

Am J Transplant. 2019 Dec 31. doi: 10.1111/ajt.15769. [Epub ahead of print]

PMID:
31891235
4.

Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.

Trecarichi EM, Giuliano G, Cattaneo C, Ballanti S, Criscuolo M, Candoni A, Marchesi F, Laurino M, Dargenio M, Fanci R, Cefalo M, Delia M, Spolzino A, Maracci L, Nadali G, Busca A, Del Principe MI, Daffini R, Simonetti E, Dragonetti G, Zannier ME, Pagano L, Tumbarello M; Haematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS) registry–Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne (SEIFEM) group, Italy.

PLoS One. 2019 Oct 29;14(10):e0224465. doi: 10.1371/journal.pone.0224465. eCollection 2019.

5.

Ceftobiprole: drug evaluation and place in therapy.

Giacobbe DR, De Rosa FG, Del Bono V, Grossi PA, Pea F, Petrosillo N, Rossolini GM, Tascini C, Tumbarello M, Viale P, Bassetti M.

Expert Rev Anti Infect Ther. 2019 Sep;17(9):689-698. doi: 10.1080/14787210.2019.1667229. Epub 2019 Sep 25.

PMID:
31553250
6.

A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group.

Marchesi F, Cattaneo C, Criscuolo M, Delia M, Dargenio M, Del Principe MI, Spadea A, Fracchiolla NS, Melillo L, Perruccio K, Alati C, Russo D, Garzia M, Brociner M, Cefalo M, Armiento D, Cesaro S, Decembrino N, Mengarelli A, Tumbarello M, Busca A, Pagano L; Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) Group.

Am J Hematol. 2019 Oct;94(10):1104-1112. doi: 10.1002/ajh.25585. Epub 2019 Aug 9.

PMID:
31321791
7.

Use of colistin in adult patients: A cross-sectional study.

Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Dalla Gasperina D, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, Viscoli C; SITA GIOVANI (Young Investigators Group of the Società Italiana Terapia Antinfettiva) and the COLI-CROSS Study Group.

J Glob Antimicrob Resist. 2019 Jun 15;20:43-49. doi: 10.1016/j.jgar.2019.06.009. [Epub ahead of print]

PMID:
31207379
8.

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.

Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, Azzini AM, Carannante N, Carnelutti A, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, García-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Le Bihan C, Luzzati R, Malbrain MLNG, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva JA, Peghin M, Raineri SM, Rautemaa-Richardson R, Schouten J, Brugnaro P, Spapen H, Tasioudis P, Timsit JF, Tisa V, Tumbarello M, van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Montravers P.

Crit Care. 2019 Jun 14;23(1):219. doi: 10.1186/s13054-019-2497-3.

9.

Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study.

Russo A, Bassetti M, Ceccarelli G, Carannante N, Losito AR, Bartoletti M, Corcione S, Granata G, Santoro A, Giacobbe DR, Peghin M, Vena A, Amadori F, Segala FV, Giannella M, Di Caprio G, Menichetti F, Del Bono V, Mussini C, Petrosillo N, De Rosa FG, Viale P, Tumbarello M, Tascini C, Viscoli C, Venditti M; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

J Infect. 2019 Aug;79(2):130-138. doi: 10.1016/j.jinf.2019.05.017. Epub 2019 May 28.

PMID:
31145911
10.

Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections.

Fiori B, D'Inzeo T, Posteraro B, Menchinelli G, Liotti FM, De Angelis G, De Maio F, Fantoni M, Murri R, Scoppettuolo G, Ventura G, Tumbarello M, Pennestrì F, Taccari F, Sanguinetti M, Spanu T.

Infect Drug Resist. 2019 May 3;12:1055-1062. doi: 10.2147/IDR.S206323. eCollection 2019.

11.

Fungaemia in haematological malignancies: SEIFEM-2015 survey.

Criscuolo M, Marchesi F, Candoni A, Cattaneo C, Nosari A, Veggia B, Verga L, Fracchiolla N, Vianelli N, Del Principe MI, Picardi M, Tumbarello M, Aversa F, Busca A, Pagano L; SEIFEM Group (Sorveglianza Epidemiologica Infezioni nelle Emopatie).

Eur J Clin Invest. 2019 May;49(5):e13083. doi: 10.1111/eci.13083. Epub 2019 Mar 7.

PMID:
30735240
12.

'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.

Del Principe MI, Dragonetti G, Verga L, Candoni A, Marchesi F, Cattaneo C, Delia M, Potenza L, Farina F, Ballanti S, Decembrino N, Castagnola C, Nadali G, Fanci R, Orciulo E, Veggia B, Offidani M, Melillo L, Manetta S, Tumbarello M, Venditti A, Busca A, Aversa F, Pagano L; Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) Group .

J Antimicrob Chemother. 2019 Apr 1;74(4):1062-1068. doi: 10.1093/jac/dky550.

PMID:
30649413
13.

Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study.

Bartoletti M, Giannella M, Lewis RE, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Torrani Cerenzia M, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D'Offizi G, Zak-Doron Y, Rodriguez-Baño J, Baldassarre M, Verucchi G, Domenicali M, Bernardi M, Viale P; ESGBIS/BICHROME study group .

Clin Infect Dis. 2019 Oct 30;69(10):1731-1739. doi: 10.1093/cid/ciz032.

PMID:
30649218
14.

The role of carbapenem-resistant pathogens in cSSTI and how to manage them.

Del Giacomo P, Losito AR, Tumbarello M.

Curr Opin Infect Dis. 2019 Apr;32(2):113-122. doi: 10.1097/QCO.0000000000000528.

PMID:
30648994
15.

Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients.

De Pascale G, Carelli S, Vallecoccia MS, Cutuli SL, Taccheri T, Montini L, Bello G, Spanu T, Tumbarello M, Cicchetti A, Urbina I, Oradei M, Marchetti M, Antonelli M.

J Crit Care. 2019 Apr;50:169-176. doi: 10.1016/j.jcrc.2018.12.001. Epub 2018 Dec 12.

PMID:
30553184
16.

Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry.

Esposito S, De Simone G, Pan A, Brambilla P, Gattuso G, Mastroianni C, Kertusha B, Contini C, Massoli L, Francisci D, Priante G, Libanore M, Bicocchi R, Borgia G, Maraolo AE, Brugnaro P, Panese S, Calabresi A, Amendola G, Savalli F, Geraci C, Tedesco A, Fossati S, Carretta A, Santantonio T, Cenderello G, Crisalli MP, Schiaroli E, Rovere P, Masini G, Ferretto R, Cascio A, Colomba C, Gioè C, Tumbarello M, Losito AR, Foti G, Prestileo T, Buscemi C, Chiara I, Iacobello C, Sonia S, Starnini G, Ialungo A, Sapienza M; Italian Society of Infectious and Tropical Diseases.

J Chemother. 2019 Feb;31(1):9-14. doi: 10.1080/1120009X.2018.1536320. Epub 2018 Dec 3.

PMID:
30508410
17.

Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia.

Giacobbe DR, Signori A, Tumbarello M, Ungaro R, Sarteschi G, Furfaro E, Mikulska M, Sanguinetti M, Posteraro B, Losito AR, De Pascale G, Del Bono V, Viscoli C.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):413-417. doi: 10.1007/s10096-018-3441-1. Epub 2018 Nov 30.

PMID:
30506332
18.

Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.

Bassetti M, Castaldo N, Cattelan A, Mussini C, Righi E, Tascini C, Menichetti F, Mastroianni CM, Tumbarello M, Grossi P, Artioli S, Carannante N, Cipriani L, Coletto D, Russo A, Digaetano M, Losito AR, Peghin M, Capone A, Nicolè S, Vena A; CEFTABUSE Study Group.

Int J Antimicrob Agents. 2019 Apr;53(4):408-415. doi: 10.1016/j.ijantimicag.2018.11.001. Epub 2018 Nov 8.

PMID:
30415002
19.

Correction to: Treatment and mortality of Klebslella pneumoniae infections in critically ill patients: should we do and predict them better?

Bassetti M, Akova M, Tumbarello M.

Intensive Care Med. 2018 Dec;44(12):2324. doi: 10.1007/s00134-018-5411-6.

PMID:
30413839
20.

Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections.

Tumbarello M, Losito AR, Giamarellou H.

Curr Opin Infect Dis. 2018 Dec;31(6):566-577. doi: 10.1097/QCO.0000000000000493. Review.

PMID:
30379732

Supplemental Content

Loading ...
Support Center